Cassava Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.

About SAVA

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.

CEO

Richard Jon Barry

CEORichard Jon Barry

Employees

Employees30

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

1998

Founded1998

Employees

Employees30

SAVA Key Statistics

Market cap

79.95M

Market cap79.95M

Price-Earnings ratio

-1.15

Price-Earnings ratio-1.15

Dividend yield

—

Dividend yield—

Average volume

1.01M

Average volume1.01M

High today

$1.70

High today$1.70

Low today

$1.60

Low today$1.60

Open price

$1.67

Open price$1.67

Volume

856.60K

Volume856.60K

52 Week high

$42.20

52 Week high$42.20

52 Week low

$1.15

52 Week low$1.15

SAVA News

TipRanks 3d

Cassava Sciences Announces Leadership Changes Amid Strategic Shift

The latest announcement is out from Cassava Sciences ( (SAVA) ). Cassava Sciences announced the retirement of its Chief Medical Officer, James W. Kupiec, effec...